BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2019
View Archived Issues
New carbapenem antibiotic shows in vitro activity against MDR Gram-negative bacterial infections
Read More
Disordered protein domains stay disordered at work
Read More
'Minor' subclones, via microenvironment, help cancer spread
Read More
Preliminary interim data presented from phase I trials of Celyad's CYAD-01 and CYAD-101
Read More
EIP Pharma initiates phase II study of neflamapimod for the treatment of cognitive deficits in HD
Read More
Trovagene initiates enrollment in phase Ib/II study of onvansertib in mCRC with KRAS mutation
Read More
A novel model for CF-associated airway colonization
Read More
Results presented from the international pivotal phase III PLEO-CMT study of PXT-3003
Read More
Pivotal phase II data presented for murlentamab in metastatic colorectal adenocarcinoma
Read More
Vaxart enters oral universal influenza vaccine collaboration with Janssen
Read More
Summit Therapeutics DDS-04 series shows efficacy in sepsis and pneumonia animal models
Read More
siRNA targeting hepatitis B virus genes described by Suzhou Ribo Life Science
Read More
Phase I/II data presented for BIVV-001 in hemophilia A
Read More
Medshine Discovery identifies EGFR/HER2/HER4 inhibitors
Read More
New idoleamine 2,3-dioxygenase 1 inhibitors discovered at Hinova Pharmaceuticals
Read More
New malaria vaccine successfully tested on Rhesus macaques
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR8 agonists
Read More
Merck & Co. identifies new PI3Kdelta inhibitors
Read More
'Human-on-a-chip' in vitro system predicts in vivo results for multiple drugs
Read More
MET-409 advances into 12-week portion of phase Ib trial in NASH
Read More
Cara initiates phase II trial of oral difelikefalin to treat pruritus in atopic dermatitis
Read More
PDE4 PET imaging with [11C](R)-rolipram undertaken in patients with McCune-Albright syndrome
Read More
Albireo studies elobixibat in phase II for NAFLD and NASH
Read More
New gain-of-function mutation in prothrombin is associated with dominant heritable thrombosis
Read More
